CAS: 212141-54-3 - Vatalanib base
Formula:C20H15ClN4
InChI:InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)
InChI key:InChIKey=YCOYDOIWSSHVCK-UHFFFAOYSA-N
SMILES:ClC1=CC=C(C=C1)NC2=NN=C(C=3C=CC=CC23)CC=4C=CN=CC4
- Synonyms:
- 1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-
- Cgp 79787
- N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine
- N-(4-Chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine
- Pynasunate
- Vatalanib
- Vatalinib
1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-
CAS:212141-54-3
Formula:
C20H15ClN4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
346.8129
Ref: AN-AG006YKS
| 50mg | 164.00 € | |
| 100mg | 293.00 € | |
| 250mg | 655.00 € |
Estimated delivery in United States, on Monday 3 Jun 2024
Ref: 7W-GP1506
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 4 Jun 2024
Ref: 54-BIFK0006
| 5mg | 93.00 € | |
| 10mg | 143.00 € | |
| 25mg | 253.00 € |
Estimated delivery in United States, on Monday 10 Jun 2024
Vatalanib free base
CAS:212141-54-3
Vatalanib is a VEGFR2/KDR inhibitor (IC50: 37 nM).
Formula:
C20H15ClN4
Purity:
99.27%
Color and Shape:
Solid
Molecular weight:
346.81
Ref: TM-T17219
| 1mg | 47.00 € | |
| 2mg | 59.00 € | |
| 5mg | 85.00 € | |
| 10mg | 115.00 € | |
| 25mg | 209.00 € | |
| 50mg | 299.00 € | |
| 100mg | 448.00 € | |
| 500mg | 1,006.00 € |
Estimated delivery in United States, on Monday 10 Jun 2024
Ref: 10-F387719
| 1g | To inquire | |
| 2g | To inquire |
Estimated delivery in United States, on Tuesday 11 Jun 2024
Vatalanib
CAS:212141-54-3
Vatalanib is a new anti-cancer drug that has been developed to inhibit the production of …
Formula:
C20H15ClN4
Purity:
Min. 95%
Molecular weight:
346.8 g/mol
Ref: 3D-MIA14154
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 15 Jul 2024
